Çiğdem Arabacı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Çiğdem Arabacı has a total of 202 co-authors. Here are the top co-authors by number of shared publications:
- Kenan Ak
Department of Clinical Microbiology, Prof. Dr. Cemil Taşcioğlu City Hospital, University of Health Sciences, Istanbul, Turkey
4 shared publications - Aysel Karataş
Department of Medical Microbiology, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey
3 shared publications - Berrin Uzun
Blood Center, Ataturk Training and Research Hospital, Izmir, Turkey
3 shared publications - Adem Karbuz
Council of Forensic Medicine, Ministry of Justice, Republic of Turkiye, Istanbul, Turkiye
2 shared publications - Emre Aygün
Department of Pediatrics, Şişli Hamidiye Etfal Training and Research Hospital, University of Health Sciences Turkey, İstanbul, Türkiye
2 shared publications - Esra Nurlu Temel
Süleyman Demirel Üniversitesi
2 shared publications
Latest Publications
- Open Access
- 24 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Changes in the microbial spectrum and antimicrobial resistance of bloodstream infections in intensive care units before and during the COVID-19 pandemic
Bloodstream infections (BSIs) are major infectious conditions associated with high morbidity and mortality, particularly in intensive care units (ICUs). In
- 24 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessChanges in the microbial spectrum and antimicrobial resistance of bloodstream infections in intensive care units before and during the COVID-19 pandemic
Bloodstream infections (BSIs) are major infectious conditions associated with high morbidity and mortality, particularly in intensive care units (ICUs). In
- Open Access
Comparative Evaluation of Strep A Throat Swab Culture Results Using the RapidFor™ Strep A Rapid Test Kit
Background/Objectives: Group A Streptococcus (GAS) pharyngitis is a frequent cause of morbidity in pediatric populations, which requires timely identification to prevent complications such as acute rheumatic fever. Rapid antigen detection tests (RADTs) are practical alternatives to throat culture. This study evaluates the diagnostic performance of the RapidFor™ Strep A test. Methods: This prospective clinical study enrolled 389 pediatric patients aged < 18 years with symptoms suggestive of streptococcal pharyngitis. Two throat swabs were collected from each patient: one for rapid antigen testing with RapidFor™ Strep A and one for culture. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. Results: Throat culture was positive in 95 of 389 patients (24.4%). The RapidFor™ Strep A test demonstrated a sensitivity of 98.95% (95% confidence interval [CI]: 94.28–99.81%) and a specificity of 96.26% (95% CI: 93.43–97.90%). The PPV was 89.52%, and the NPV was 99.65%. Agreement with culture was excellent (κ = 0.919); in particular, false-positive results accounted for 2.8% and false-negative results accounted for 1.05%. Fever was the strongest clinical indicator associated with positive results. Conclusions: The RapidFor™ Strep A test showed very high diagnostic accuracy compared with throat culture, including an excellent NPV (99.6%), which supports its reliability for ruling out GAS pharyngitis in pediatric settings. The test is an effective screening tool that facilitates timely antibiotic therapy.
Open AccessComparative Evaluation of Strep A Throat Swab Culture Results Using the RapidFor™ Strep A Rapid Test Kit
Background/Objectives: Group A Streptococcus (GAS) pharyngitis is a frequent cause of morbidity in pediatric populations, which requires timely identification to prevent complications such as acute rheumatic fever. Rapid antigen detection tests (RADTs) are practical alternatives to throat culture. This study evaluates the diagnostic performance of the RapidFor™ Strep A test. Methods: This prospective clinical study enrolled 389 pediatric patients aged < 18 years with symptoms suggestive of streptococcal pharyngitis. Two throat swabs were collected from each patient: one for rapid antigen testing with RapidFor™ Strep A and one for culture. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. Results: Throat culture was positive in 95 of 389 patients (24.4%). The RapidFor™ Strep A test demonstrated a sensitivity of 98.95% (95% confidence interval [CI]: 94.28–99.81%) and a specificity of 96.26% (95% CI: 93.43–97.90%). The PPV was 89.52%, and the NPV was 99.65%. Agreement with culture was excellent (κ = 0.919); in particular, false-positive results accounted for 2.8% and false-negative results accounted for 1.05%. Fever was the strongest clinical indicator associated with positive results. Conclusions: The RapidFor™ Strep A test showed very high diagnostic accuracy compared with throat culture, including an excellent NPV (99.6%), which supports its reliability for ruling out GAS pharyngitis in pediatric settings. The test is an effective screening tool that facilitates timely antibiotic therapy.
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 19 (4) , 246-255
Pediyatri Kliniğinde Vankomisine Dirençli Enterokok İzolatlarının Değerlendirilmesi: Bir Eğitim ve Araştırma Hastanesi Deneyimi
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 19 (4) , 246-255
Pediyatri Kliniğinde Vankomisine Dirençli Enterokok İzolatlarının Değerlendirilmesi: Bir Eğitim ve Araştırma Hastanesi Deneyimi
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 19 (4) , 250-259
Evaluation of Vancomycin-Resistant Enterococcus Isolates in Pediatric Clinic: An Experience From A Teaching and Research Hospital
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 19 (4) , 250-259
Evaluation of Vancomycin-Resistant Enterococcus Isolates in Pediatric Clinic: An Experience From A Teaching and Research Hospital
- 21 August 2025
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 39 (6) , 425-430
Effect of Inferior Turbinate Radiofrequency Procedure on Nasal Flora: A Prospective Study
Background: Inferior turbinate hypertrophy is a common cause of chronic nasal obstruction, and radiofrequency treatment has become an effective minimally invasive option for management. However, the impact of this procedure on nasal bacterial flora and the need for postoperative antibiotics remains unclear. Objective: To investigate the effect of inferior turbinate radiofrequency treatment on the nasal cavity bacterial flora and the need for postoperative antibiotics. Methods: Forty-five voluntary patients aged 18 to 65, who were referred to the Otorhinolaryngology clinic between 11/2023 and 02/2024 due to chronic nasal obstruction, were included in the study. The patients had noninfective inferior turbinate hypertrophy, were recommended for inferior turbinate radiofrequency treatment, and agreed to undergo the procedure. Before and one month after the procedure, nasal swabs were taken from the patients and sent to the Clinical Microbiology Department for culture. The microorganisms isolated from both swabs were compared. The statistical analysis of the study data was conducted using SPSS 26.0 software. Results: No significant difference was observed in the total bacterial colonization count after the radiofrequency procedure compared to before the procedure ( p = .44). There was no significant difference in the total count of normal flora elements and potentially pathogenic bacteria between the pre and post procedure ( p = .10, p = .23). Among the isolated normal flora microorganisms, no significant difference was observed in the bacterial colonization count for all species except coagulase-negative staphylococci, in which a significant decrease was detected ( p > .05, p = .004). Conclusion: The data from this study suggest that inferior turbinate radiofrequency treatment does not significantly affect nasal flora bacterial colonization and does not cause a significant increase in the number and variety of pathogenic bacteria, thereby indicating that postoperative antibiotic therapy is not necessary. However, further studies with a larger sample size are required.
- 21 August 2025
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 39 (6) , 425-430
Effect of Inferior Turbinate Radiofrequency Procedure on Nasal Flora: A Prospective Study
Background: Inferior turbinate hypertrophy is a common cause of chronic nasal obstruction, and radiofrequency treatment has become an effective minimally invasive option for management. However, the impact of this procedure on nasal bacterial flora and the need for postoperative antibiotics remains unclear. Objective: To investigate the effect of inferior turbinate radiofrequency treatment on the nasal cavity bacterial flora and the need for postoperative antibiotics. Methods: Forty-five voluntary patients aged 18 to 65, who were referred to the Otorhinolaryngology clinic between 11/2023 and 02/2024 due to chronic nasal obstruction, were included in the study. The patients had noninfective inferior turbinate hypertrophy, were recommended for inferior turbinate radiofrequency treatment, and agreed to undergo the procedure. Before and one month after the procedure, nasal swabs were taken from the patients and sent to the Clinical Microbiology Department for culture. The microorganisms isolated from both swabs were compared. The statistical analysis of the study data was conducted using SPSS 26.0 software. Results: No significant difference was observed in the total bacterial colonization count after the radiofrequency procedure compared to before the procedure ( p = .44). There was no significant difference in the total count of normal flora elements and potentially pathogenic bacteria between the pre and post procedure ( p = .10, p = .23). Among the isolated normal flora microorganisms, no significant difference was observed in the bacterial colonization count for all species except coagulase-negative staphylococci, in which a significant decrease was detected ( p > .05, p = .004). Conclusion: The data from this study suggest that inferior turbinate radiofrequency treatment does not significantly affect nasal flora bacterial colonization and does not cause a significant increase in the number and variety of pathogenic bacteria, thereby indicating that postoperative antibiotic therapy is not necessary. However, further studies with a larger sample size are required.
- 7 March 2025
- Published by Academician Publishing
- p. 237-256
Rickettsia, Orientia, Ehrlichia ve Anaplasma
Rickettsiales Takımı’nda yer alan bakteriler, zorunlu hücre içi bakterilerdir; bu nedenle, konak hücre dışında yaşayamazlar. Gram-negatif özellik gösterirler ancak hücre duvarları Gram boyasıyla zor boyanır. ATP üretmek için konak hücre kaynaklarını kullanırlar. Vektörler (keneler, pireler, bitler ve akarlar) aracılığıyla bulaşır. Özellikle vasküler endotel veya beyaz kan hücrelerini enfekte ederler. Vaskülit nedeniyle damar geçirgenliği bozulur, organ yetmezlikleri görülebilir. Rickettsia türleri, Tifüs Grubu: Epidemik (R. prowazekii) ve Endemik Tifüs (R. typhi), Çalılık Tifüsü (O. tsutsugamushi) ile Benekli Ateş Grubu: Kayalık Dağlar Benekli Ateşi (R. rickettsii) ve Akdeniz Benekli Ateşi (R. conorii) olarak sınıflandırılır. Anaplasmataceae türleri: Ehrlichia, Anaplasma, Neorickettsia ve Wolbachia olmak üzere dört cinse ayrılmıştır. Bu türler, insan monosit ve makrofajlarını enfekte eder. İnsan Monositik Ehrlichyozu’ndan sorumlu olan E. chaffeensis, İnsan Granülositik Ehrlichyozu’nun etiyolojik ajanı olan E. ewingii ve İnsan Granülositik Anaplasmozu’nun ajanı olan A. phagocytophilum’dur. Neorickettsia sennetsu, Uzak Doğu’da görülen Sennetsu ateşinin etkenidir. Ateş, döküntü, baş ve kas ağrısı gibi klinik bulgularla seyreder. Öyküde kene, bit, pire ve akar sokma ya da ısırma öyküsü vardır. Laboratuvar tanısında mikroskopi, kültür, seroloji ve moleküler yöntemler yer alır. Tedavide doksisiklin ilk tercih edilecek ilaçtır. Korunmada vektör kontrolü önemlidir. Bunun için böcek kovucular ve koruyucu kıyafetler kullanılabilir.
- 7 March 2025
- Published by Academician Publishing
- p. 237-256
Rickettsia, Orientia, Ehrlichia ve Anaplasma
Rickettsiales Takımı’nda yer alan bakteriler, zorunlu hücre içi bakterilerdir; bu nedenle, konak hücre dışında yaşayamazlar. Gram-negatif özellik gösterirler ancak hücre duvarları Gram boyasıyla zor boyanır. ATP üretmek için konak hücre kaynaklarını kullanırlar. Vektörler (keneler, pireler, bitler ve akarlar) aracılığıyla bulaşır. Özellikle vasküler endotel veya beyaz kan hücrelerini enfekte ederler. Vaskülit nedeniyle damar geçirgenliği bozulur, organ yetmezlikleri görülebilir. Rickettsia türleri, Tifüs Grubu: Epidemik (R. prowazekii) ve Endemik Tifüs (R. typhi), Çalılık Tifüsü (O. tsutsugamushi) ile Benekli Ateş Grubu: Kayalık Dağlar Benekli Ateşi (R. rickettsii) ve Akdeniz Benekli Ateşi (R. conorii) olarak sınıflandırılır. Anaplasmataceae türleri: Ehrlichia, Anaplasma, Neorickettsia ve Wolbachia olmak üzere dört cinse ayrılmıştır. Bu türler, insan monosit ve makrofajlarını enfekte eder. İnsan Monositik Ehrlichyozu’ndan sorumlu olan E. chaffeensis, İnsan Granülositik Ehrlichyozu’nun etiyolojik ajanı olan E. ewingii ve İnsan Granülositik Anaplasmozu’nun ajanı olan A. phagocytophilum’dur. Neorickettsia sennetsu, Uzak Doğu’da görülen Sennetsu ateşinin etkenidir. Ateş, döküntü, baş ve kas ağrısı gibi klinik bulgularla seyreder. Öyküde kene, bit, pire ve akar sokma ya da ısırma öyküsü vardır. Laboratuvar tanısında mikroskopi, kültür, seroloji ve moleküler yöntemler yer alır. Tedavide doksisiklin ilk tercih edilecek ilaçtır. Korunmada vektör kontrolü önemlidir. Bunun için böcek kovucular ve koruyucu kıyafetler kullanılabilir.
- 7 March 2025
- Published by Academician Publishing
- p. 77-92
Neiserria ve Moraxella
Son yıllarda 16S rRNA dizisi analizi ve tüm genom dizilemesi tekniklerinin geliştirilmesinin ardından Neisseriaceae ailesini oluşturan bakteriler kapsamlı bir şekilde yeniden sınıflandırılmıştır. Bu ailede tıbbi önemi olan Neisseria, Eikenella ve Kingella olmak üzere üç alt grup bakteri cinsi bulunmaktadır. Neisseria cinsi bakterilerin üyeleri arasında, insan ve hayvanların normal florasının parçası olan nonpatojen türlerin yanında, patojen olan türler de bulunmaktadır. Diğer bakterilere göre sınırlı biyosentez yeteneklerine sahip olmaları nedeniyle, konakçılarının florasına adaptasyonları iyidir. Bu grupta yer alan insan için patojen türlerinden Neisseria gonorrhoeae cinsel yolla bulaşan dünya genelinde yaygın olan gonore (bel soğukluğu) hastalığına neden olur. Neisseria meningitidis ise dünya çapında fatal seyirli epidemik menenjit, menenjitle beraber seyreden sepsise ile karakterize meningokoksemik hastalığa neden olabilen yüksek mortalite riski olan bir patojendir. Bu nedenle, hızlı ve güvenilir tanı yöntemleri ile hastaların tanısı, tedaviye başlanması ve temaslıların profilaksiye alınması kritik önem taşımaktadır. Neisseria gonorrhoea ise geçmişte antimikrobiyal ilaçlarla kolaylıkla tedavi edilebilir hastalık iken son yıllarda çeşiti antibiyotiklere dirençli türlerin dünya genelinde giderek yaygınlaşması, tedavide sorun oluşturmaktadır. Neisseriaceae ailesi içindeki Kingella ve Eikenella gibi diğer türler, insanların orofarinksinde kolonize halde bulunup fırsatçı enfeksiyonlara neden olmaktadır.
- 7 March 2025
- Published by Academician Publishing
- p. 77-92
Neiserria ve Moraxella
Son yıllarda 16S rRNA dizisi analizi ve tüm genom dizilemesi tekniklerinin geliştirilmesinin ardından Neisseriaceae ailesini oluşturan bakteriler kapsamlı bir şekilde yeniden sınıflandırılmıştır. Bu ailede tıbbi önemi olan Neisseria, Eikenella ve Kingella olmak üzere üç alt grup bakteri cinsi bulunmaktadır. Neisseria cinsi bakterilerin üyeleri arasında, insan ve hayvanların normal florasının parçası olan nonpatojen türlerin yanında, patojen olan türler de bulunmaktadır. Diğer bakterilere göre sınırlı biyosentez yeteneklerine sahip olmaları nedeniyle, konakçılarının florasına adaptasyonları iyidir. Bu grupta yer alan insan için patojen türlerinden Neisseria gonorrhoeae cinsel yolla bulaşan dünya genelinde yaygın olan gonore (bel soğukluğu) hastalığına neden olur. Neisseria meningitidis ise dünya çapında fatal seyirli epidemik menenjit, menenjitle beraber seyreden sepsise ile karakterize meningokoksemik hastalığa neden olabilen yüksek mortalite riski olan bir patojendir. Bu nedenle, hızlı ve güvenilir tanı yöntemleri ile hastaların tanısı, tedaviye başlanması ve temaslıların profilaksiye alınması kritik önem taşımaktadır. Neisseria gonorrhoea ise geçmişte antimikrobiyal ilaçlarla kolaylıkla tedavi edilebilir hastalık iken son yıllarda çeşiti antibiyotiklere dirençli türlerin dünya genelinde giderek yaygınlaşması, tedavide sorun oluşturmaktadır. Neisseriaceae ailesi içindeki Kingella ve Eikenella gibi diğer türler, insanların orofarinksinde kolonize halde bulunup fırsatçı enfeksiyonlara neden olmaktadır.
- Open Access
- 7 March 2025
- Published by Academician Publishing
Tıp Fakülteleri için Mikrobiyoloji ve İmmunoloji Kitabı
- 7 March 2025
- Published by Academician Publishing
Open AccessTıp Fakülteleri için Mikrobiyoloji ve İmmunoloji Kitabı
- Open Access
- 18 October 2024
- Published by MDPI AG in Antibiotics
- Vol. 13 (10) , 990
Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region
Background: Ceftazidime–avibactam (CAZ-AVI) is recommended as first-line treatment for Oxacillinase-48 (OXA-48) β-Lactamase-producing carbapenem-resistant Enterobacterales (CRE) infections, while polymyxin-based combination therapies (PBCTs) are used as a last resort when CAZ-AVI is unavailable. Research comparing the effectiveness of CAZ-AVI and PBCT in CRE blood stream infections (CRE-BSIs) is limited, mostly focusing on Klebsiella pneumoniae carbapenemase (KPC)-producing isolates. In Turkey, OXA-48 is endemic and OXA-48-Like is common. Therefore, our study aimed to compare the impact of these treatments on 30-day mortality in patients with CRE-BSIs in endemic regions. Methods: Retrospective data from January 2019 to May 2023 were collected from four tertiary healthcare centers in Istanbul. Demographic, clinical, and outcome data of ICU patients treated with CAZ-AVI monotherapy or PBCT for CRE-BSIs were analyzed. The effect on 30-day survival was evaluated using Cox regression analysis post propensity score matching (PSM). Results: Out of 151 patients, 44.4% (n: 67) received CAZ-AVI and 55.6% (n: 84) received PBCT. All-cause mortality rates were 20% (n: 13) with CAZ-AVI and 36.9% (n: 31) with PBCT. Cox regression analysis post PSM indicated CAZ-AVI monotherapy significantly reduced the mortality risk compared to PBCT (HR: 0.16, 95%CI: 0.07–0.37, p < 0.001), while age increased the risk (HR: 1.02 per year, 95% CI 1.0–1.04, p: 0.01). Conclusions: In OXA-48-predominant areas, CAZ-AVI demonstrated significantly lower mortality in patients with CRE-BSIs compared to PBCT. The results were attributed to the pharmacokinetic and pharmacodynamic disadvantages of polymyxins compared to CAZ-AVI, and the impact of age-related physical conditions. Therefore, CAZ-AVI should be the preferred treatment for CRE-BSIs in OXA-48-endemic regions.
- 18 October 2024
- Published by MDPI AG in Antibiotics
- Vol. 13 (10) , 990
Open AccessCeftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region
Background: Ceftazidime–avibactam (CAZ-AVI) is recommended as first-line treatment for Oxacillinase-48 (OXA-48) β-Lactamase-producing carbapenem-resistant Enterobacterales (CRE) infections, while polymyxin-based combination therapies (PBCTs) are used as a last resort when CAZ-AVI is unavailable. Research comparing the effectiveness of CAZ-AVI and PBCT in CRE blood stream infections (CRE-BSIs) is limited, mostly focusing on Klebsiella pneumoniae carbapenemase (KPC)-producing isolates. In Turkey, OXA-48 is endemic and OXA-48-Like is common. Therefore, our study aimed to compare the impact of these treatments on 30-day mortality in patients with CRE-BSIs in endemic regions. Methods: Retrospective data from January 2019 to May 2023 were collected from four tertiary healthcare centers in Istanbul. Demographic, clinical, and outcome data of ICU patients treated with CAZ-AVI monotherapy or PBCT for CRE-BSIs were analyzed. The effect on 30-day survival was evaluated using Cox regression analysis post propensity score matching (PSM). Results: Out of 151 patients, 44.4% (n: 67) received CAZ-AVI and 55.6% (n: 84) received PBCT. All-cause mortality rates were 20% (n: 13) with CAZ-AVI and 36.9% (n: 31) with PBCT. Cox regression analysis post PSM indicated CAZ-AVI monotherapy significantly reduced the mortality risk compared to PBCT (HR: 0.16, 95%CI: 0.07–0.37, p < 0.001), while age increased the risk (HR: 1.02 per year, 95% CI 1.0–1.04, p: 0.01). Conclusions: In OXA-48-predominant areas, CAZ-AVI demonstrated significantly lower mortality in patients with CRE-BSIs compared to PBCT. The results were attributed to the pharmacokinetic and pharmacodynamic disadvantages of polymyxins compared to CAZ-AVI, and the impact of age-related physical conditions. Therefore, CAZ-AVI should be the preferred treatment for CRE-BSIs in OXA-48-endemic regions.
- Open Access
- 25 December 2023
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 36 (4)
Macrolide-Lincosamide-Streptogramin B (MLSB) Resistance Phenotypes and Mupirocin/Fusidic Acid Activity in Staphylococcus aureus Isolates from Clinical Samples
Objective: This study aimed to determine the prevalence and phenotypes of macrolide, lincosamide, and streptogramın B (MLSB) resistance in Staphylococcus aureus strains isolated from clinical samples and to assess the efficacy of mupirocin and fusidic acid against these isolates. Methods: Between January 2021 and December 2022, S. aureus strains isolated from clinical samples were identified by VITEK® MS (bioMérieux, France), and their antibiotic susceptibilities were determined using VITEK®2 (bioMérieux, France). The disk approximation method was used to determine the MLSB resistance phenotypes using erythromycin (15 μg) and clindamycin (2 μg). For fusidic acid, a MIC of ≤1 mg/L was considered susceptible, and a MIC of >1 mg/L was considered resistant. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2020 guidelines were followed, with a MIC of ≤1 mg/L considered sensitive, a MIC of 2-256 mg/L indicating low-level resistance, and a MIC of >256 mg/L indicating high-level resistance for mupirocin. Results: The MLSB resistance phenotypes of the strains were as follows: 8.9% inducible (iMLSB), 4.6% chromosomal (cMLSB), 12.8% MS type, 0.8% L type, and 72.92% erythromycin and clindamycin sensitive were detected. Mupirocin resistance was detected 7.2% in 250 S. aureus strains, 14.3% in MRSA, and 2.1% in MSSA. Fusidic acid resistance was seen at 10.7% in 711 S. aureus strains, 20.1% in MRSA, and 5.5% in MSSA. Conclusion: When erythromycin resistance is detected in MRSA isolates, it is essential to determine macrolide resistance phenotypes with a simple and easy method such as the D-test and investigate clindamycin resistance for choosing appropriate antibiotics. Mupirocin resistance in S. aureus strains was higher in MRSA isolates than in MSSA isolates. It is noteworthy that fusidic acid resistance is frequently seen in both MRSA and MSSA isolates that are susceptible to erythromycin and clindamycin. In infections where fusidic acid is commonly used, it is necessary to monitor antibiotic susceptibilities closely.
- 25 December 2023
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 36 (4)
Open AccessMacrolide-Lincosamide-Streptogramin B (MLSB) Resistance Phenotypes and Mupirocin/Fusidic Acid Activity in Staphylococcus aureus Isolates from Clinical Samples
Objective: This study aimed to determine the prevalence and phenotypes of macrolide, lincosamide, and streptogramın B (MLSB) resistance in Staphylococcus aureus strains isolated from clinical samples and to assess the efficacy of mupirocin and fusidic acid against these isolates. Methods: Between January 2021 and December 2022, S. aureus strains isolated from clinical samples were identified by VITEK® MS (bioMérieux, France), and their antibiotic susceptibilities were determined using VITEK®2 (bioMérieux, France). The disk approximation method was used to determine the MLSB resistance phenotypes using erythromycin (15 μg) and clindamycin (2 μg). For fusidic acid, a MIC of ≤1 mg/L was considered susceptible, and a MIC of >1 mg/L was considered resistant. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2020 guidelines were followed, with a MIC of ≤1 mg/L considered sensitive, a MIC of 2-256 mg/L indicating low-level resistance, and a MIC of >256 mg/L indicating high-level resistance for mupirocin. Results: The MLSB resistance phenotypes of the strains were as follows: 8.9% inducible (iMLSB), 4.6% chromosomal (cMLSB), 12.8% MS type, 0.8% L type, and 72.92% erythromycin and clindamycin sensitive were detected. Mupirocin resistance was detected 7.2% in 250 S. aureus strains, 14.3% in MRSA, and 2.1% in MSSA. Fusidic acid resistance was seen at 10.7% in 711 S. aureus strains, 20.1% in MRSA, and 5.5% in MSSA. Conclusion: When erythromycin resistance is detected in MRSA isolates, it is essential to determine macrolide resistance phenotypes with a simple and easy method such as the D-test and investigate clindamycin resistance for choosing appropriate antibiotics. Mupirocin resistance in S. aureus strains was higher in MRSA isolates than in MSSA isolates. It is noteworthy that fusidic acid resistance is frequently seen in both MRSA and MSSA isolates that are susceptible to erythromycin and clindamycin. In infections where fusidic acid is commonly used, it is necessary to monitor antibiotic susceptibilities closely.